Publication: The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
| dc.contributor.author | YUMUK, PERRAN FULDEN | |
| dc.contributor.authors | Eralp, Y.; Ak, N.; Yilmazbayhan, D.; Ozkan, B.; Ferhatoglu, F.; Demirkazik, A.; Sak, S. Dizbay; Dilege, S.; Tanju, S.; Toker, A.; Bulutay, P.; Firat, P.; Mandel, N. Molinas; Kilickap, S.; Onder, S.; Dikmen, E.; Alan, O.; Yumuk, P. F.; Bozkurtlar, E.; Lacin, T.; Ozturk, A.; Kocaturk, C.; Karapinar, K.; Urer, N.; Uluc, B. Oyan | |
| dc.date.accessioned | 2022-03-14T15:18:30Z | |
| dc.date.accessioned | 2026-01-10T19:46:26Z | |
| dc.date.available | 2022-03-14T15:18:30Z | |
| dc.date.issued | 2019-10 | |
| dc.identifier.doi | 10.1016/j.jtho.2019.08.1934 | |
| dc.identifier.eissn | 1556-1380 | |
| dc.identifier.issn | 1556-0864 | |
| dc.identifier.uri | https://hdl.handle.net/11424/246098 | |
| dc.identifier.wos | WOS:000492162204418 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE INC | |
| dc.relation.ispartof | JOURNAL OF THORACIC ONCOLOGY | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | NSCLC | |
| dc.subject | Adjuvant Chemotherapy | |
| dc.subject | Early Stage | |
| dc.title | The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study | |
| dc.type | conferenceObject | |
| dc.type.sub | meetingabstract | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | S893 | |
| oaire.citation.issue | 10 | |
| oaire.citation.startPage | S892 | |
| oaire.citation.title | JOURNAL OF THORACIC ONCOLOGY | |
| oaire.citation.volume | 14 |
Files
Original bundle
1 - 1 of 1